October 27, 2014

Ceva invests US$23 million to expand French production facility

 

Ceva Santé Animale, a global veterinary health group, has invested US$23 million for the expansion of its sterile products plant in Libourne, France.

The facility, which hires 130 people, was inaugurated on October 3, 2014, and will increase Ceva's injectable drug production capacity.

Ceva's investment will improve the plant's controlled-atmosphere production areas. In addition, an extension of 500 square meters in workspace was already completed, along with the renovation of 1,000 square meters of existing floor areas and installation of new manufacturing and filling equipment.

With employee welfare in mind, the facility has also been designed to limit direct exposure to products handled by workers with the use of automated closed-circuit processes and dust extraction arms.

"This project was an essential step to secure the plant's competitive edge. 18 million 100ml vials can be produced by the plant each year, and the first order for China will be leaving next week", said Emmanuel Coudré, the director of the Libourne site.

"This high-performance industrial facility uses modern technologies in a state-of-the-art environment to comply with the highest international standards of good manufacturing practice (GMP) and provide optimal working conditions for production personnel."